REFRAME
Dead / Abandoned — Abandoned — no statement of use filed (as of 18 Aug 2025)
What this means for you
This application is over — abandoned 18 Aug 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98023354
- Mark type
- Word mark
- Filed
- 01 Jun 2023
- Published for opposition
- 21 May 2024
- Abandoned
- 18 Aug 2025
- Attorney of record
- Karen Won
Goods and services
- Class 042 — Scientific and technological services: Medical scientific research, medical scientific development, and medical scientific testing of antibody-drug conjugates and cancer therapies; Providing medical scientific research information in the field of antibody-drug conjugates and cancer therapies; Scientific investigations for medical purposes featuring clinical trials
Owner
- Sutro Biopharma, Inc., South San Francisco, CA, US
- Sutro Biopharma, Inc., South San Francisco, CA, US
Prosecution history
- 18 Aug 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 18 Aug 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Jan 2025 — SOU EXTENSION 1 GRANTED
- 15 Jan 2025 — SOU EXTENSION 1 FILED
- 15 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 16 Jul 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 21 May 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 May 2024 — PUBLISHED FOR OPPOSITION
- 01 May 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 16 Apr 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 19 Mar 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 19 Mar 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 19 Mar 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 19 Dec 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED